Cardiac Amyloidosis Versus Other Restrictive Cardiomyopathies: A Retrospective Analysis of Cardiovascular Outcomes

Andrew Sagalov1, Waqas Ullah2, Yevgeniy Brailovsky3

  • 1Department of Internal Medicine, SIU School of Medicine, Springfield, IL, USA.

Insights

Cardiac amyloidosis increases stroke and ventricular tachycardia risks compared to other restrictive cardiomyopathies. In-hospital mortality and most arrhythmias were similar, but further analysis of amyloidosis subtypes is needed.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Electrophysiology

Background:

  • Cardiac amyloidosis (CA) and other restrictive cardiomyopathies (RCM) have distinct cardiovascular risk profiles.
  • Increased screening has led to more CA diagnoses, necessitating analysis of its outcomes.
  • Previous literature has not well-characterized the arrhythmic burden and cardiovascular risks of CA versus other RCMs.

Purpose of the Study:

  • To compare the cardiovascular risks and arrhythmic burden of cardiac amyloidosis with other types of restrictive cardiomyopathies.
  • To analyze outcomes including stroke, ventricular tachycardia, atrial fibrillation, and in-hospital mortality.

Main Methods:

  • A retrospective analysis of the National Inpatient Sample (NIS) database from 2016-2019.
  • Inclusion of adult patients diagnosed with cardiac amyloidosis or other RCMs (e.g., hemochromatosis, cardiac sarcoid).
  • Discharge-weighted analysis using survey regressions to account for sample characteristics and weights.

Main Results:

  • Cardiac amyloidosis (N=8365) showed a significantly increased risk of stroke (OR=3.91) and ventricular tachycardia (OR=1.98) compared to other RCM (N=4980).
  • CA had a decreased risk of atrial fibrillation (OR=0.56).
  • In-hospital mortality (P=.72) and risks of heart block and supraventricular arrhythmias were similar between groups.

Conclusions:

  • Cardiac amyloidosis is associated with higher risks of stroke and ventricular tachycardia than other RCMs.
  • In-hospital mortality and most arrhythmias did not significantly differ between CA and other RCMs.
  • Subgroup analysis of light chain (AL) and transthyretin (ATTR) amyloidosis is recommended to further define CA cardiovascular risks.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
828
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761